Niagen Bioscience Inc
NAGEHealthcare|Biotechnology|US
$2.07
-0.04 (-1.66%)
Tangible Book / Share
$0.98
Graham Number
$1.75
Ownership Breakdown
65.7%
Float
79.1M
Shares Outstanding
52.0M
Float Shares
Major Holders (1)
Combined: 5.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| The Vanguard Group | Investment adviser | 5.04% | 4,021,650 | Oct 31, 2025 | 13D/G |
Insider Trades (26)
Last 4 quarters: 1,063,062.405 acquired · 86,667 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel | Jun 30, 2026 | AWARD | 2,314 | $2.71 | $6.3K | Form 4 |
| Pamir Ozan | Chief Financial Officer | Jun 30, 2026 | AWARD | 4,255 | $2.71 | $11.5K | Form 4 |
| Fried Robert N | director, officer: Chief Executive Officer | Jun 30, 2026 | AWARD | 1,106 | $2.71 | $3.0K | Form 4 |
| YU Wing Tak Wendy | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Ng Wang Yu Gary | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Cohen Ann | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Patrick Kristin | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Shahbazi Hamed | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Rubin Steven D | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Jaksch Frank L Jr | director | Jun 24, 2026 | AWARD | 31,746 | $3.45 | $109.5K | Form 4 |
| Fried Robert N | director, officer: Chief Executive Officer | Apr 24, 2026 | OPTION EX. | 20,000 | $2.61 | $52.2K | Form 4 |
| Fried Robert N | director, officer: Chief Executive Officer | Apr 24, 2026 | OPTION EX. | 20,000 | $2.61 | $52.2K | Form 4 |
| Lopez Carlos Luis | SVP, General Counsel | Feb 19, 2026 | AWARD | 41,420 | $4.94 | $204.6K | Form 4 |
| Pamir Ozan | Chief Financial Officer | Feb 19, 2026 | AWARD | 62,131 | $4.94 | $306.9K | Form 4 |
| Fried Robert N | director, officer: Chief Executive Officer | Feb 19, 2026 | AWARD | 503,937 | $4.94 | $2.5M | Form 4 |
| Pamir Ozan | Chief Financial Officer | Nov 14, 2025 | BUY | 4,464.962 | $6.81 | $30.4K | Form 4 |
| Pamir Ozan | Chief Financial Officer | Nov 14, 2025 | BUY | 2,220.443 | $6.85 | $15.2K | Form 4 |
| Shahbazi Hamed | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| YU Wing Tak Wendy | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| Patrick Kristin | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| Rubin Steven D | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| Ng Wang Yu Gary | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| Cohen Ann | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| Jaksch Frank L Jr | director | Jun 24, 2025 | AWARD | 20,000 | $14.13 | $282.6K | Form 4 |
| Fried Robert N | director, officer: Chief Executive Officer | Apr 9, 2025 | OPTION EX. | 66,667 | $3.30 | $220.0K | Form 4 |
| Fried Robert N | director, officer: Chief Executive Officer | Apr 9, 2025 | OPTION EX. | 66,667 | $3.30 | $220.0K | Form 4 |